Q4 2021 Results slide image

Q4 2021 Results

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix Vas Narasimhan Chief Executive Officer 48 Investor Relations | Q4 2021 Results NOVARTIS | Reimagining Medicine
View entire presentation